Compare RGEN & NNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGEN | NNN |
|---|---|---|
| Founded | 1981 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 8.5B |
| IPO Year | 1995 | 1995 |
| Metric | RGEN | NNN |
|---|---|---|
| Price | $118.58 | $42.54 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 7 |
| Target Price | ★ $175.64 | $44.17 |
| AVG Volume (30 Days) | 833.5K | ★ 1.2M |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 5.71% |
| EPS Growth | ★ 286.96 | N/A |
| EPS | 0.86 | ★ 2.07 |
| Revenue | $141,236,000.00 | ★ $926,213,000.00 |
| Revenue This Year | $14.31 | $5.36 |
| Revenue Next Year | $14.41 | $5.14 |
| P/E Ratio | $136.99 | ★ $20.29 |
| Revenue Growth | ★ 35.10 | 6.55 |
| 52 Week Low | $102.97 | $35.80 |
| 52 Week High | $175.77 | $46.03 |
| Indicator | RGEN | NNN |
|---|---|---|
| Relative Strength Index (RSI) | 45.29 | 39.52 |
| Support Level | $112.53 | $40.89 |
| Resistance Level | $130.56 | $43.18 |
| Average True Range (ATR) | 4.44 | 0.77 |
| MACD | 1.17 | -0.26 |
| Stochastic Oscillator | 67.86 | 21.29 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
NNN REIT Inc is a real estate investment trust that acquires, owns, invests in, and develops high-quality properties mainly leased under long-term net leases with minimal capital expenditure requirements. The company focuses mainly on retail properties, with a portfolio including convenience stores, automotive service properties, restaurants, theatres, entertainment venues, dealerships, and other retail-related assets. Primary business objectives emphasize retail properties, and it may invest in a wide variety of property and tenant types, leases, mortgages, loans secured by personal property, loans secured by partnership or membership interests, and securities of other REITs or other issuers.